A recent survey designed to measure public attitudes about the Precision Medicine Initiative (PMI) Cohort Program has shown that most respondents were willing to participate in this nationwide research. The PMI Cohort Program is a longitudinal research effort that aims to engage 1 million or more U.S. participants to help improve prevention and treatment of […]
The National Human Genome Research Institute a component of the National Institutes of Health (NIH) and the Department of Health and Human Services (DHHS), is seeking exceptional candidates for the position of Director, Division of Genome Sciences. The ideal candidate will have the knowledge and expertise to lead NHGRI's funding for extramural research […]
The genetic origins of a fierce Sardinian dog (also called Fonni's dogs for the city of the same name) mirror recent studies that also traced the genetic origins of human Sardinians to the Middle East and Hungary, according to scientists at the National Human Genome Research Institute. Sequencing the whole genome of Fonni's dogs revealed clues abou […]
I-Corps offers researchers unique opportunities to learn how to turn discoveries into new technologies and to participate in the national innovation ecosystem. More at https://www.nsf.gov/news/special_reports/i-corps/index.jsp?WT.mc_id=USNSF_51 This is an NSF News item.
Outbreaks of infectious diseases such as Zika increasingly threaten global public health. Scientists expect five such new diseases to emerge each year. To find out whether our interaction with the environment is somehow responsible, the Ecology and Evolution of Infectious Diseases (EEID) program -- a joint effort of the National Science Foundation (NSF), Nat […]
The National Science Foundation (NSF) has awarded five new grants to teach entrepreneurship and to support research and innovation at regional hubs across the United States under its Innovation Corps (I-Corps™) program. The innovation hubs, known as I-Corps nodes, provide the research infrastructure and training to help researchers transition ... More at htt […]
A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment.
The precision medicine approach involving DNA sequencing to pinpoint specific alterations that can be targeted with anti-cancer therapies is becoming an alternate treatment avenue for those with poor-responding cancers.